ARDS nursing: assessment, interventions, and NCLEX review

Acute respiratory distress syndrome (ARDS) is a life-threatening form of respiratory failure characterized by rapid onset, bilateral pulmonary infiltrates, refractory hypoxemia, and reduced lung compliance — all occurring in the absence of cardiogenic pulmonary edema. It develops as a consequence of a major physiological insult and carries a mortality rate of 35–45% in severe cases. For nursing students, ARDS is essential knowledge: it appears in the ICU, step-down unit, and on the NCLEX, and managing it requires precise assessment, vigilant monitoring, and familiarity with lung-protective ventilation strategies.

This reference covers the Berlin Definition and severity classification, pathophysiology, causes, clinical presentation, nursing assessment, mechanical ventilation interventions including prone positioning, and NCLEX-style practice questions. Pair this with the ABG interpretation cheat sheet, the pneumonia nursing reference, and the sepsis nursing reference — all three conditions overlap closely with ARDS in clinical practice.

Berlin definition and severity classification

The Berlin Definition, published by the ARDS Definition Task Force in JAMA in 2012, replaced the older American-European Consensus Conference criteria and remains the standard diagnostic framework today. It requires all four of the following criteria to be met:

1. Timing: Onset within 1 week of a known clinical insult or new/worsening respiratory symptoms
2. Imaging: Bilateral opacities on chest X-ray or CT — opacities that are not fully explained by effusions, lobar or lung collapse, or nodules
3. Origin of edema: Respiratory failure not fully explained by cardiac failure or fluid overload (requires objective assessment — e.g., echocardiography — to exclude hydrostatic edema if no risk factor is present)
4. Oxygenation: PaO2/FiO2 ratio < 300 mmHg with a minimum PEEP or CPAP of 5 cmH2O

Severity is classified by the P/F ratio at the time of ARDS diagnosis. The P/F ratio (PaO2 divided by FiO2 expressed as a decimal) is the cornerstone assessment tool and is covered in detail in the nursing assessment section below.

Pathophysiology

ARDS is the common endpoint of a wide variety of insults. Whether the trigger is pneumonia, sepsis, aspiration, or trauma, the lung responds through a shared pathway of diffuse alveolar damage (DAD). Pathophysiology unfolds in two overlapping phases.

Exudative phase (days 1–7)

The exudative phase begins within hours of the precipitating injury. Injury to the alveolar-capillary membrane — either from direct lung injury or from circulating inflammatory mediators — triggers a massive cytokine storm. Pro-inflammatory cytokines including TNF-α, IL-1, IL-6, and IL-8 recruit neutrophils into the alveolar space. Activated neutrophils release proteases, reactive oxygen species, and leukotrienes, causing further membrane destruction.

The damaged alveolar-capillary barrier becomes highly permeable. Protein-rich fluid leaks from the pulmonary capillaries into the interstitium and alveolar air spaces, forming the hallmark non-cardiogenic pulmonary edema of ARDS. Critically, this edema is driven by increased permeability — not by elevated hydrostatic pressure as in cardiogenic pulmonary edema. The pulmonary artery wedge pressure (PAWP) in ARDS is typically ≤ 18 mmHg, reflecting normal left heart filling pressures.

Type II pneumocytes, which produce surfactant, are destroyed during this phase. Loss of surfactant dramatically increases alveolar surface tension, causing widespread alveolar collapse (atelectasis). The result is severely reduced lung compliance, ventilation-perfusion (V/Q) mismatch, and intrapulmonary shunting — blood perfuses collapsed alveoli but receives no oxygenation, producing the refractory hypoxemia that defines ARDS. This hypoxemia does not respond to supplemental oxygen alone because the problem is shunting, not simply reduced oxygen delivery.

Proliferative phase (days 7–21+)

If the patient survives the exudative phase, the lungs enter a proliferative (fibroproliferative) phase. Type II pneumocytes proliferate in an attempt to restore the alveolar epithelium. Fibroblasts are recruited and begin laying down collagen. In many patients, this resolves without permanent impairment. In others — particularly those with severe ARDS — progressive fibrosis develops, permanently reducing lung compliance and diffusing capacity.

The distinction between ARDS and cardiogenic pulmonary edema is clinically critical and a frequent NCLEX testing point. Both present with bilateral infiltrates and hypoxemia, but the mechanisms and management differ fundamentally. ARDS is driven by permeability edema (normal or low PAWP, no evidence of left heart failure); cardiogenic pulmonary edema is driven by elevated hydrostatic pressure (elevated PAWP, signs of heart failure). Conservative fluid management is appropriate in ARDS; diuresis is the intervention for cardiogenic edema.

Common causes

ARDS causes are categorized as direct (pulmonary) or indirect (extrapulmonary), depending on whether the initial injury strikes the lung itself or reaches it via the systemic circulation.

Direct (pulmonary) causes

• Pneumonia — bacterial, viral (including influenza, SARS-CoV-2), and fungal pneumonia are all established triggers
• Aspiration of gastric contents — a particularly destructive cause due to the low pH of aspirated material
• Pulmonary contusion — blunt chest trauma causing direct alveolar injury
• Near-drowning — freshwater or saltwater aspiration damages surfactant and the alveolar membrane
• Toxic inhalation — smoke inhalation, chemical burns to the airways

Indirect (extrapulmonary) causes

• Sepsis — the single most common cause of ARDS, accounting for approximately 40% of cases. Circulating endotoxins and inflammatory mediators reach the pulmonary vasculature and trigger the alveolar-capillary injury cascade
• Major trauma — especially combined with shock and massive transfusion
• Transfusion-related acute lung injury (TRALI) — ARDS occurring within 6 hours of a blood product transfusion; mediated by donor antibodies reacting with recipient leukocytes
• Severe pancreatitis — activated pancreatic enzymes enter the systemic circulation and trigger systemic inflammation
• Burns — both direct inhalation injury and systemic inflammatory response

Understanding the precipitating cause matters for nursing care because treating the underlying condition is as important as managing the respiratory failure itself. A patient with sepsis-associated ARDS requires aggressive source control and antibiotics alongside ventilator management.

Clinical presentation

ARDS presents acutely — by definition, within 1 week of the precipitating insult, though most patients deteriorate within 12–48 hours of the triggering event.

Respiratory findings:

• Rapid, shallow breathing — respiratory rate often exceeds 30 breaths/minute
• Refractory hypoxemia — SpO2 fails to improve adequately despite supplemental oxygen; supplemental O2 alone is insufficient when significant shunting is present
• Use of accessory muscles (sternocleidomastoid, intercostals, subcostal retractions)
• Bilateral crackles on auscultation — reflecting fluid-filled alveoli
• Cyanosis in severe cases

Neurological findings:

• Anxiety and agitation — often an early sign of hypoxemia
• Confusion and altered mental status as hypoxemia worsens
• Decreased level of consciousness in severe cases

Hemodynamic findings:

• Tachycardia
• Hypotension if the underlying cause (e.g., sepsis) has produced circulatory compromise
• Signs of decreased organ perfusion in severe cases

Imaging:

• Chest X-ray: bilateral, diffuse opacities (“white out” in severe cases) — does not spare the central regions as cardiogenic edema characteristically does
• CT chest: heterogeneous infiltrates with dependent consolidation and non-dependent ground-glass opacities — reflects the uneven distribution of ARDS lung injury

Nursing assessment

P/F ratio calculation

The PaO2/FiO2 ratio is the primary tool for classifying ARDS severity and tracking response to treatment. It is calculated from arterial blood gas results.

Formula: P/F ratio = PaO2 (mmHg) ÷ FiO2 (expressed as a decimal)

Worked example: A mechanically ventilated patient has a PaO2 of 72 mmHg on FiO2 0.60 (60% oxygen). P/F ratio = 72 ÷ 0.60 = 120 mmHg → This places the patient in the severe ARDS category (P/F < 100 at some centers uses <100; the Berlin Definition uses <100 for severe). At P/F 120, the patient meets criteria for prone positioning evaluation.

A second example: PaO2 of 160 mmHg on FiO2 0.80 → P/F = 160 ÷ 0.80 = 200 mmHg → moderate ARDS.

Monitoring the trend in P/F ratio over time is as important as a single value. Improving P/F ratio (rising number) signals improving oxygenation. Worsening P/F ratio signals disease progression or a new complication.

Refer to the ABG interpretation cheat sheet for a full guide to reading arterial blood gas results in context.

Systematic assessment priorities

• Oxygenation: Continuous SpO2 monitoring; ABG as ordered (typically every 4–8 hours in acute ARDS, or after any ventilator change). Note: pulse oximetry is less reliable at SpO2 < 80% — ABG is the gold standard for P/F ratio calculation
• Respiratory mechanics: Respiratory rate, work of breathing, accessory muscle use, tidal volume and minute ventilation on the ventilator display, peak inspiratory pressure, plateau pressure, driving pressure
• Breath sounds: Bilateral crackles; monitor for changes that could indicate pneumothorax (sudden absence of breath sounds, tracheal deviation) — a risk with positive pressure ventilation
• Mental status: Agitation and confusion are early hypoxemia signs; reassess frequently, especially after sedation adjustments
• Fluid balance: Strict intake/output monitoring; daily weights; monitor for fluid overload while avoiding under-resuscitation if hemodynamically unstable
• Hemodynamics: Heart rate, blood pressure, MAP, urine output; in severe ARDS, arterial line monitoring is standard for continuous blood pressure and frequent ABG sampling
• Skin and perfusion: Color, capillary refill, peripheral pulses; monitor dependent areas for pressure injury — especially critical during prone positioning sessions

Nursing interventions

Mechanical ventilation: lung-protective strategy

Mechanical ventilation is the cornerstone of ARDS management. The landmark ARDSNet ARMA trial (NEJM, 2000) demonstrated that low tidal volume ventilation (6 mL/kg ideal body weight) reduced 28-day mortality from 39.8% to 31% compared with traditional tidal volumes of 12 mL/kg. This established lung-protective ventilation as the standard of care.

Key parameters for lung-protective ventilation:

• Tidal volume (Vt): 4–8 mL/kg ideal body weight (IBW); target 6 mL/kg IBW. IBW is calculated from height, not actual body weight — this is a critical distinction. Using actual body weight in obese patients will result in dangerously high tidal volumes
• Plateau pressure: < 30 cmH2O. Plateau pressure reflects alveolar distending pressure and is measured during an inspiratory hold maneuver. Pressures above 30 cmH2O cause barotrauma and volutrauma
• Driving pressure: < 15 cmH2O. Driving pressure = plateau pressure − PEEP. Emerging evidence suggests driving pressure may be more directly associated with mortality than plateau pressure alone
• PEEP (positive end-expiratory pressure): Titrated to maintain alveolar recruitment and improve oxygenation without causing overdistension. Typical range: 5–15 cmH2O in moderate-severe ARDS; higher PEEP strategies may be used in severe ARDS
• FiO2: Titrated to maintain SpO2 88–95% (permissive hypoxemia targets are acceptable in ARDS to avoid oxygen toxicity)

Permissive hypercapnia: Low tidal volumes may allow CO2 to rise (hypercapnia). A pH of 7.20–7.45 with elevated PaCO2 is generally tolerated (“permissive hypercapnia”) rather than increasing tidal volumes to normalize CO2 at the cost of lung injury.

Prone positioning

Prone positioning is a well-evidenced intervention for severe ARDS. The PROSEVA trial (NEJM, 2013) demonstrated that early prone positioning (within 36 hours of intubation) for ≥ 16 hours/day reduced 28-day mortality from 32.8% to 16.0% in patients with severe ARDS (P/F < 150 mmHg) — one of the largest mortality benefits demonstrated for any single intervention in critical care.

Indications: P/F ratio < 150 mmHg on FiO2 ≥ 0.60 and PEEP ≥ 5 cmH2O Duration: > 12 hours per day (PROSEVA used > 16 hours) Mechanism: Prone positioning redistributes lung edema from dependent to non-dependent zones, recruits collapsed dorsal alveoli, and improves V/Q matching — all improving oxygenation without increasing FiO2 or PEEP

Nursing responsibilities during prone positioning:

• Requires a coordinated team of 4–5 staff to turn safely
• Protect all pressure points: forehead, chin, chest, pelvis, knees — use foam padding
• Secure all lines, tubes, and the endotracheal tube before turning — ETT dislodgement is a life-threatening complication
• Monitor for facial edema, conjunctival edema, and corneal abrasions — use artificial tears and eye tape
• Assess for hemodynamic instability during and immediately after turning
• Maintain HOB 15–30° (reverse Trendelenburg in prone) to reduce facial edema and VAP risk

Conservative fluid management

Once the patient is hemodynamically stable, a conservative fluid strategy (targeting a neutral or slightly negative fluid balance) is preferred in ARDS. The FACTT trial demonstrated that conservative fluid management reduces ventilator days and ICU length of stay without increasing organ failure. Nursing closely monitors:

• Hourly urine output (target ≥ 0.5 mL/kg/hr, but be cautious about aggressive diuresis)
• Daily weights
• Fluid balance totals per shift

Neuromuscular blockade

In severe ARDS, early neuromuscular blockade (NMB) with cisatracurium for 48 hours may reduce patient-ventilator dyssynchrony and improve oxygenation, though evidence on mortality benefit has evolved since the ACURASYS and ROSE trials. When NMB is in use, nursing must:

• Ensure adequate sedation is in place before administering NMB — a paralyzed patient who is undersedated is awake but unable to communicate distress
• Monitor with train-of-four (TOF) peripheral nerve stimulation
• Perform all range-of-motion, eye care, and pressure injury prevention passively, as the patient cannot reposition

Ventilator-associated pneumonia (VAP) prevention bundle

Mechanically ventilated ARDS patients are at high risk for VAP. Standard VAP prevention bundle:

• Head of bed elevated 30–45° at all times (unless prone)
• Oral care with chlorhexidine every 4 hours
• Endotracheal tube cuff pressure maintenance (20–30 cmH2O)
• Subglottic secretion drainage
• Daily sedation vacation and spontaneous breathing trial assessment

Nutritional support

Early enteral nutrition (within 24–48 hours) is recommended for ventilated ARDS patients. Nurses verify feeding tube placement, monitor gastric residuals per protocol, and coordinate with nutrition services. Prone positioning does not preclude enteral feeding, though rates may be reduced during the turn.

NCLEX-style practice questions

Question 1

A mechanically ventilated patient with ARDS has a PaO2 of 60 mmHg on FiO2 of 0.80. What is the patient’s P/F ratio, and what severity category does this represent?

A) P/F 75 — severe ARDS B) P/F 120 — severe ARDS C) P/F 75 — moderate ARDS D) P/F 48 — severe ARDS

Answer: A — P/F 75, severe ARDS

Rationale: P/F ratio = PaO2 ÷ FiO2 = 60 ÷ 0.80 = 75 mmHg. A P/F ratio < 100 mmHg meets the Berlin Definition criteria for severe ARDS.

Question 2

A patient weighing 100 kg (IBW 70 kg) is intubated for ARDS. The respiratory therapist has set the tidal volume at 600 mL. What is the nurse’s priority action?

A) Document the ventilator settings and continue monitoring B) Notify the provider — the tidal volume should be based on ideal body weight C) Increase PEEP to improve oxygenation D) Request a stat chest X-ray

Answer: B — Notify the provider; tidal volume should be based on IBW

Rationale: Lung-protective ventilation targets 6 mL/kg ideal body weight, not actual body weight. For this patient, target Vt = 6 × 70 = 420 mL. A tidal volume of 600 mL (8.6 mL/kg IBW) exceeds safe limits and risks barotrauma, volutrauma, and ventilator-induced lung injury.

Question 3

A nurse is caring for a patient with severe ARDS (P/F ratio 88 mmHg). The intensivist discusses initiating prone positioning. Which response by the nurse demonstrates correct understanding?

A) “Prone positioning is contraindicated when the P/F ratio is below 100.” B) “The patient should be placed prone for at least 12 hours per day.” C) “Prone positioning will correct the underlying cause of ARDS.” D) “We should wait 72 hours after intubation before starting prone positioning.”

Answer: B — Prone positioning for at least 12 hours per day

Rationale: The PROSEVA trial demonstrated a significant mortality benefit (28-day mortality 16% vs. 32.8%) with prone positioning for > 16 hours/day in severe ARDS (P/F < 150 mmHg). The minimum effective duration is > 12 hours/day. Prone positioning is indicated — the P/F ratio of 88 meets the criterion of < 150. Option D is incorrect: PROSEVA enrolled patients within 36 hours of intubation, and early prone positioning is preferred.

Question 4

A patient presents with bilateral infiltrates on chest X-ray, SpO2 88% on 60% oxygen via non-rebreather mask, and a history of aspiration 18 hours ago. The nurse suspects ARDS. Which finding would most help distinguish ARDS from cardiogenic pulmonary edema?

A) Bilateral crackles on auscultation B) Tachycardia and tachypnea C) Pulmonary artery wedge pressure of 16 mmHg D) PaO2 of 55 mmHg on ABG

Answer: C — PAWP of 16 mmHg

Rationale: In ARDS, pulmonary edema is non-cardiogenic — caused by increased alveolar-capillary permeability rather than elevated left heart filling pressures. A PAWP ≤ 18 mmHg (normal) in the setting of bilateral infiltrates and hypoxemia supports ARDS over cardiogenic pulmonary edema (which would show an elevated PAWP, typically > 18–20 mmHg). Bilateral crackles, tachycardia, tachypnea, and hypoxemia occur in both conditions and do not differentiate them.

Question 5

The nurse is reviewing ventilator settings for a patient with ARDS. The plateau pressure is 34 cmH2O. What is the nurse’s most appropriate action?

A) Continue monitoring — plateau pressure up to 40 cmH2O is acceptable in ARDS B) Notify the provider — plateau pressure should be < 30 cmH2O C) Increase the PEEP to reduce the plateau pressure D) Suction the endotracheal tube to relieve airway obstruction

Answer: B — Notify the provider; plateau pressure should be < 30 cmH2O

Rationale: Lung-protective ventilation requires maintaining plateau pressure < 30 cmH2O to prevent barotrauma and ventilator-induced lung injury (VILI). A plateau pressure of 34 cmH2O exceeds this threshold. The appropriate response is to notify the provider for a ventilator adjustment — typically a further reduction in tidal volume. Increasing PEEP would generally worsen the plateau pressure, not improve it.

Question 6

A patient with ARDS has been ordered for neuromuscular blockade (cisatracurium) for 48 hours. Before administering the first dose, what is the nurse’s priority assessment?

A) Verify the patient has adequate IV access B) Confirm the patient has adequate sedation and analgesia in place C) Check the latest ABG for the P/F ratio D) Confirm the PEEP setting on the ventilator

Answer: B — Confirm adequate sedation and analgesia

Rationale: Neuromuscular blocking agents paralyze voluntary muscles but do not provide sedation or analgesia. A patient who is awake and aware during paralysis experiences profound distress but cannot communicate it. Ensuring adequate sedation and analgesia before initiating NMB is the priority nursing action and an essential safety check.

Related references

For comprehensive nursing care of patients with conditions commonly associated with ARDS, see:

• Pneumonia nursing: complete reference guide — pneumonia is among the most common direct triggers of ARDS
• Sepsis nursing reference — sepsis is the leading cause of ARDS; sepsis management and ARDS management overlap significantly
• ABG interpretation cheat sheet — essential for calculating P/F ratio and monitoring respiratory status in ARDS

This article is for educational purposes. Always apply clinical judgment and follow your institution’s evidence-based protocols when caring for patients with ARDS.